Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: an updated systematic review of randomized controlled trials
doi: 10.1056/NEJMra1615439 Summary Keywords diabetic peripheral neuropathy, glucagon-like peptide-1 receptor agonists, neuroprotection, inflammation, oxidative stress Citation Liu C, Wu T and Ren N (2024) Glucagon-like peptide-1 receptor agonists for the management of diabetic peripheral neuropathy
The Tohoku journal of experimental medicine
Why Any of This Matters for Jaw Surgery Patients A few practical things to know if youre thinking about jaw, TMJ, or airway surgery while youre on one of these medications
Frustration is the path to quitting
Oral GLP-1 products, he said, create additional API demand because of the quantity required per dose